1 / 2

CHINA Genomic Biomarker Market

The genomic biomarker market in China is estimated to grow significantly at a CAGR of over 17% during the forecast period. China has emerged as a strong player in the biotechnology sector that results from the huge investments in R&D by the Chinese government. Chinese life science sector has progressively grown in the last years as a result of strong R&D and funding. The Chinese government has invested enormously in the cancer diagnostics making it a prominent region for the biomarker industry.

nabeelomr
Télécharger la présentation

CHINA Genomic Biomarker Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The genomic biomarker market in China is estimated to grow significantly at a CAGR of over 17% during the forecast period. China has emerged as a strong player in the biotechnology sector that results from the huge investments in R&D by the Chinese government. Chinese life science sector has progressively grown in the last years as a result of strong R&D and funding. The Chinese government has invested enormously in the cancer diagnostics making it a prominent region for the biomarker industry. China’s substantial patient populations in urban markets and research capability in genome sequencing have formed substantial opportunities for foreign companies. China has a clear market development priority for the IVD industry in the areas of cancer diagnostics, sequencing-based cancer assays, and companion diagnostics. (Get 15% Discount on Buying this Report) Get Report Sample Copy @ https://www.omrglobal.com/request-sample/china-genomic- biomarkers-market The genomic biomarker market is segmented on the basis of application and end-user. On the basis of application, the market is segmented into oncology, cardiology, neurology, and others. There is a huge scope for the market in the oncology segment due to the increasing prevalence of cancer. On the basis of end-user, the market is segmented into hospitals and diagnostic. A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/china-genomic-biomarkers-market Market Segmentation China Genomic Biomarker Market by Application Oncology Cardiology Neurology Others China Genomic Biomarker Market by End-User Hospitals Diagnostic & Research Laboratories

  2. Company Profiles Becton, Dickson, and Co. BGI Group Cancer Genetics, Inc. Complete Genomics Inc. Denovo Biopharma Epigenomics AG F-Hoffman-La Roche Ltd. Ipsos Group Novartis AG Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For https://www.omrglobal.com/report-customization/china-genomic-biomarkers-market More Customized Data, Request for Report Customization @ About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

More Related